insights_auto
Why is THYROCARE up 4.23%?
Dive Deeperchevron_right
THYROCARE:NSE
Thyrocare Technologies Ltd
₹475.50
arrow_upward
+4.23%(+19.30) 1D
Oct 22, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for THYROCARE...
Open
₹451.00
High
₹476.80
Low
₹450.90
Mkt. cap
75.68B
Avg. vol.
280.72K
Volume
454.96K
Dividend
1.96%
Quarterly dividend
₹2.33
Ex-dividend date
Jun 23, 2026
P/E ratio
43.21
52-wk high
₹662.00
52-wk low
₹342.55
EPS
₹11.00
Shares outstanding
52.76M
No. of employees
2K
Open
₹451.00
High
₹476.80
Low
₹450.90
Mkt. cap
75.68B
Avg. vol.
280.72K
Volume
454.96K
Dividend
1.96%
Quarterly dividend
₹2.33
Ex-dividend date
Jun 23, 2026
P/E ratio
43.21
52-wk high
₹662.00
52-wk low
₹342.55
EPS
₹11.00
Shares outstanding
52.76M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
38 minutes ago
He makes 3 decisions a year (and beat the S&P 500 for 11 years)
36Kr
·
28 minutes ago
Why Did Hilton Delist from the New York Stock Exchange? Unveiling the NYSE Exit Mystery
Profile
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
About Thyrocare Technologies Ltd
CEO-
Employees1.91K
Founded1996
HeadquartersNavi Mumbai, Maharashtra, India
SectorHealth care provider
Websitethyrocare.com